Cervical cancer screening intervals, 2006 to 2009: moving beyond annual testing.
نویسندگان
چکیده
up by biomedical journals to include in a cross-sectional study is a testament to the widespread adoption of these policies and their importance to publishers of medical and scientific research. At JAMA Internal Medicine, our Instructions for Authors (www.jamainternalmed.com/public/forauthors .aspx) include a detailed outline of our stated editorial policies on authorship and the roles of sponsors and funders. The full intention of this careful outline is to enable authors to respond fully, transparently, and accurately to the requirements for submission and consideration for publication by the journal. Once a group of authors enters a publishing agreement with us—which begins at the time of manuscript submission and consideration of the work by the journal—we require verification of the roles and responsibilitiesof theauthorsand those supporting theirwork. Authors may—and should—refer to the Authorship Criteria section of the Instructions to fulfill this requirement for submission:
منابع مشابه
Use of claims data to estimate annual cervical cancer screening percentages in Portland metropolitan area, Oregon.
BACKGROUND Human papillomavirus (HPV) vaccine should reduce cervical dysplasia before cervical cancer. However, dysplasia diagnosis is screening-dependent. Accurate screening estimates are needed. PURPOSE To estimate the percentage of women in a geographic population that has had cervical cancer screening. METHODS We analyzed claims data for (Papanicolau) Pap tests from 2008-2012 to estimat...
متن کاملPnm-17: Cost Effectiveness of Human Papillomavirus Testing in Cervical Cancer Diagnosis
Background: Epidemiological studies are shown robust association between human papillomavirus (HPV) and cervical cancer. From 1990 HPV was known as a necessary but insufficient cause of cervical invasive cancer. The purpose of this study was to evaluate the cost effectiveness of HPV test in cervical cancer screening. Materials and Methods: This is a systematic review article; the newest scienti...
متن کاملپیشگیری ،HPV ،سرطان سرویکس، واکسیناسیون
Cervical cancer is the second most common gynecologic cancer. A steady 70% annual decline in mortality from cervical cancers has been observed since the mid 20th century after the introduction of widespread papanicolaou cytological screening. But also cervical cancer continues to be an important world health problem for women. Cervical cancer is one of the best- understood neoplasm given its we...
متن کاملChallenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists.
BACKGROUND Current cervical cancer prevention recommendations include human papillomavirus (HPV) vaccination, Pap and HPV co-testing, and Pap testing at 3- to 5-year intervals. PURPOSE To examine attitudes, practice patterns, and barriers related to HPV vaccination and cervical cancer screening guidelines among U.S. obstetrician-gynecologists. METHODS In 2011-2012, a national sample of memb...
متن کاملA new generation of studies of human papillomavirus DNA testing in cervical cancer screening.
JNCI Vol. 101, Issue 23 | December 2, 2009 “All zoogles are boogles. You saw a boogle. Is it a zoogle?” Question in an SAT examination (Nassim Nicholas Taleb in “The Black Swan”) “Not necessarily” is the resounding answer to this thought experiment, in analogy to the central argument in the debate on the clinical utility of human papillomavirus (HPV) testing in cervical cancer screening. Virtua...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- JAMA internal medicine
دوره 173 10 شماره
صفحات -
تاریخ انتشار 2013